Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 23% ± 6% | |
astrocyte | 5 studies | 29% ± 10% | |
natural killer cell | 4 studies | 18% ± 4% | |
ciliated cell | 4 studies | 28% ± 5% | |
Mueller cell | 4 studies | 33% ± 17% | |
fibroblast | 4 studies | 19% ± 4% | |
GABAergic neuron | 4 studies | 34% ± 9% | |
glutamatergic neuron | 4 studies | 32% ± 9% | |
mucosal invariant T cell | 3 studies | 21% ± 3% | |
epithelial cell | 3 studies | 31% ± 9% | |
smooth muscle cell | 3 studies | 22% ± 6% | |
retina horizontal cell | 3 studies | 22% ± 4% | |
endothelial cell of lymphatic vessel | 3 studies | 21% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 6% | |
pericyte | 3 studies | 19% ± 1% | |
type I pneumocyte | 3 studies | 20% ± 2% | |
type II pneumocyte | 3 studies | 19% ± 1% | |
T cell | 3 studies | 20% ± 2% | |
interneuron | 3 studies | 38% ± 15% | |
neuron | 3 studies | 20% ± 4% | |
oligodendrocyte | 3 studies | 24% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 28% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1356.09 | 180 / 180 | 100% | 13.70 | 429 / 430 |
breast | 100% | 1862.91 | 458 / 459 | 100% | 20.75 | 1115 / 1118 |
lung | 100% | 2852.97 | 576 / 578 | 100% | 15.94 | 1153 / 1155 |
esophagus | 99% | 1734.65 | 1437 / 1445 | 100% | 16.58 | 183 / 183 |
intestine | 100% | 1740.04 | 965 / 966 | 99% | 14.60 | 524 / 527 |
uterus | 100% | 2145.84 | 170 / 170 | 99% | 17.81 | 455 / 459 |
thymus | 100% | 2528.24 | 653 / 653 | 99% | 20.91 | 598 / 605 |
stomach | 100% | 1494.09 | 358 / 359 | 99% | 13.95 | 283 / 286 |
prostate | 100% | 1531.51 | 244 / 245 | 99% | 18.36 | 497 / 502 |
brain | 98% | 1328.62 | 2588 / 2642 | 100% | 27.00 | 703 / 705 |
kidney | 100% | 1160.15 | 89 / 89 | 97% | 14.29 | 878 / 901 |
bladder | 100% | 1501.24 | 21 / 21 | 96% | 12.69 | 486 / 504 |
adrenal gland | 99% | 1009.05 | 256 / 258 | 95% | 10.60 | 218 / 230 |
skin | 100% | 1263.71 | 1803 / 1809 | 94% | 13.18 | 443 / 472 |
pancreas | 92% | 716.73 | 303 / 328 | 98% | 15.40 | 175 / 178 |
liver | 96% | 869.03 | 218 / 226 | 89% | 8.46 | 363 / 406 |
spleen | 100% | 979.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.60 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.16 | 1 / 1 |
blood vessel | 100% | 2051.57 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1764.15 | 1201 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 971.79 | 786 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1140.33 | 838 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 5.72 | 58 / 80 |
lymph node | 0% | 0 | 0 / 0 | 52% | 3.21 | 15 / 29 |
peripheral blood | 33% | 215.13 | 311 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045721 | Biological process | negative regulation of gluconeogenesis |
GO_0009785 | Biological process | blue light signaling pathway |
GO_0032868 | Biological process | response to insulin |
GO_2000323 | Biological process | negative regulation of glucocorticoid receptor signaling pathway |
GO_0033762 | Biological process | response to glucagon |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0014823 | Biological process | response to activity |
GO_0045744 | Biological process | negative regulation of G protein-coupled receptor signaling pathway |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0007623 | Biological process | circadian rhythm |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0045722 | Biological process | positive regulation of gluconeogenesis |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0019915 | Biological process | lipid storage |
GO_0042754 | Biological process | negative regulation of circadian rhythm |
GO_0006094 | Biological process | gluconeogenesis |
GO_0009416 | Biological process | response to light stimulus |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_2000001 | Biological process | regulation of DNA damage checkpoint |
GO_2000850 | Biological process | negative regulation of glucocorticoid secretion |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0042770 | Biological process | signal transduction in response to DNA damage |
GO_0042593 | Biological process | glucose homeostasis |
GO_0005739 | Cellular component | mitochondrion |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0009882 | Molecular function | blue light photoreceptor activity |
GO_0003677 | Molecular function | DNA binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0071949 | Molecular function | FAD binding |
GO_0003914 | Molecular function | DNA (6-4) photolyase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0003904 | Molecular function | deoxyribodipyrimidine photo-lyase activity |
GO_0019902 | Molecular function | phosphatase binding |
GO_0070888 | Molecular function | E-box binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | CRY1 |
Protein name | Cryptochrome circadian regulator 1 Cryptochrome-1 |
Synonyms | hCG_1811683 PHLL1 |
Description | FUNCTION: Transcriptional repressor which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. CRY1 and CRY2 have redundant functions but also differential and selective contributions at least in defining the pace of the SCN circadian clock and its circadian transcriptional outputs. More potent transcriptional repressor in cerebellum and liver than CRY2, though more effective in lengthening the period of the SCN oscillator. On its side, CRY2 seems to play a critical role in tuning SCN circadian period by opposing the action of CRY1. With CRY2, is dispensable for circadian rhythm generation but necessary for the development of intercellular networks for rhythm synchrony. Capable of translocating circadian clock core proteins such as PER proteins to the nucleus. Interacts with CLOCK-BMAL1 independently of PER proteins and is found at CLOCK-BMAL1-bound sites, suggesting that CRY may act as a molecular gatekeeper to maintain CLOCK-BMAL1 in a poised and repressed state until the proper time for transcriptional activation. Represses the CLOCK-BMAL1 induced transcription of BHLHE40/DEC1. Represses the CLOCK-BMAL1 induced transcription of ATF4, MTA1, KLF10 and NAMPT (By similarity). May repress circadian target genes expression in collaboration with HDAC1 and HDAC2 through histone deacetylation. Mediates the clock-control activation of ATR and modulates ATR-mediated DNA damage checkpoint. In liver, mediates circadian regulation of cAMP signaling and gluconeogenesis by binding to membrane-coupled G proteins and blocking glucagon-mediated increases in intracellular cAMP concentrations and CREB1 phosphorylation. Inhibits hepatic gluconeogenesis by decreasing nuclear FOXO1 levels that down-regulates gluconeogenic gene expression (By similarity). Besides its role in the maintenance of the circadian clock, is also involved in the regulation of other processes. Represses glucocorticoid receptor NR3C1/GR-induced transcriptional activity by binding to glucocorticoid response elements (GREs). Plays a key role in glucose and lipid metabolism modulation, in part, through the transcriptional regulation of genes involved in these pathways, such as LEP or ACSL4 (By similarity). Represses PPARD and its target genes in the skeletal muscle and limits exercise capacity (By similarity). Plays an essential role in the generation of circadian rhythms in the retina (By similarity). Represses the transcriptional activity of NR1I2 (By similarity). . |
Accessions | Q16526 H0YHT0 ENST00000008527.10 ENST00000549356.1 A2I2P0 |